
doi: 10.1007/bf00181702
pmid: 8125665
From May 1985 to March 1990, 18 cases of Enneking's stage II synovial sarcoma of the extremities were treated by a combination of surgery and CYVADIC chemotherapy with or without radiotherapy. The average follow up was 34.7 months. The estimated 5-year survival rate was 78.4% and the continuously disease-free 5-year survival rate was 44.4%. The results were improved by adequate surgery or chemotherapy when local recurrence or metastases had developed. The combination of surgery and CYVADIC chemotherapy with or without radiotherapy was considered to be an effective method of treating this tumour.
Adult, Male, Leg, Lung Neoplasms, Adolescent, Middle Aged, Combined Modality Therapy, Survival Rate, Sarcoma, Synovial, Arm, Humans, Female, Neoplasm Recurrence, Local, Child, Follow-Up Studies
Adult, Male, Leg, Lung Neoplasms, Adolescent, Middle Aged, Combined Modality Therapy, Survival Rate, Sarcoma, Synovial, Arm, Humans, Female, Neoplasm Recurrence, Local, Child, Follow-Up Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
